| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9451 | 
      | Human Intestinal Absorption | HIA+ | 1.0000 | 
      | Caco-2 Permeability | Caco2+ | 0.8918 | 
      | P-glycoprotein Substrate | Substrate | 0.6937 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.6917 | 
                                                     | Non-inhibitor | 0.9113 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.7501 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.5425 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8402 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8948 | 
      | CYP450 3A4 Substrate | Substrate | 0.7593 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.7389 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9327 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9268 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.7832 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.8505 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7223 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8493 | 
                                                                    | Non-inhibitor | 0.6626 | 
      | AMES Toxicity | Non AMES toxic | 0.9194 | 
      | Carcinogens | Non-carcinogens | 0.9370 | 
      | Fish Toxicity | High FHMT | 0.9612 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.8856 | 
      | Honey Bee Toxicity | High HBT | 0.8283 | 
      | Biodegradation | Not ready biodegradable | 0.9606 | 
      | Acute Oral Toxicity | III | 0.5729 | 
      | Carcinogenicity (Three-class) | Non-required | 0.4138 |